Chemoimmunotherapy Drugs with Antiviral Activity to Treat Patients with Lung Cancer and COVID-19, a Narrative Review

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Olfati Ali; Soufivand Parviz; Saadatfar Abdollah

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: MENS HEALTH JOURNAL Year:2023 | Volume:7 | Issue:1 Page(s): 1-6

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Chemoimmunotherapy Drugs with Antiviral Activity to Treat Patients with Lung Cancer and COVID-19, a Narrative Review

Author(s)

Olfati Ali | Soufivand Parviz | Saadatfar Abdollah | Issue Writer Certificate

Keywords

COVID-19Q4

antiviral activityQ4

chemotherapeutic drugsQ4

lung cancerQ4

Abstract

Every year lung cancer is a cause of high morbidity and mortality in the human population. However, since 31 December 2019, the coronavirus disease 2019 [COVID-19] had importantly affected various degrees of pulmonary regions. Therefore, patients with lung cancer must be the priority group for COVID-19 prevention, treatment, and vaccination during the COVID-19 pandemic. Until now, clinicians and patients know that most individuals with respiratory distress and/or those with a weakened immune system are more susceptible to COVID-19, however, the associations with lung cancer remain unclear. Here, we present the combination of common chemotherapeutic drugs with a historical antiviral activity that may be too immunosuppressive to eliminate COVID-19-infected cells in patients with lung cancer. This review will help understand the preferred chemoimmunotherapy drugs for severe forms of COVID-19 [SARS-CoV-2] in these patients.

Cites